A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance) Meeting Abstract
| Authors: | Wei, A. C. C.; Ou, F. S.; Shi, Q.; O'Reilly, E. M.; Meyerhardt, J. A.; Wolff, R. A.; Kindler, H. L.; Evans, D. B.; Deshpande, V.; Misdraji, J.; Tamm, E. P.; Sahani, D.; Moore, M. J.; Newman, E.; Merchant, N. B.; Berlin, J.; Goff, L. W.; Pisters, P. W. T.; Posner, M. C. |
| Abstract Title: | A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 229s |
| Language: | English |
| ACCESSION: | WOS:000442916002010 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4112 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4112 -- Source: Wos |
